Directory
>
Ouzama Henry
Ouzama Henry
Associate Director | Dynavax Technologies
North Carolina, Raleigh, United States
Ouzama Henry
Summary
Ouzama Henry is a seasoned executive in the field of clinical development with nearly two decades of experience, primarily within the pharmaceutical industry. He currently serves as the Vice President of Clinical Development at Dynavax Technologies, where he leads innovative projects in vaccine development. Previously, he held significant roles at Merck and GSK, including Director and Senior Director positions, showcasing his expertise in biologicals and vaccine research. Ouzama is passionate about human health, which is reflected in his academic background, holding an MD from Harvard Medical School and a Master's in Epidemiology from Columbia University. His leadership in clinical research has contributed to advancements in vaccine technology. Ouzama's career is marked by a commitment to improving public health outcomes through scientific innovation and collaboration. He is known for his strategic vision and ability to navigate complex clinical landscapes.
Ouzama Henry
Work Experience
Vice President Clinical Development at
Dynavax Technologies
June 2022 - Present
Ouzama Henry
Education
Harvard Medical School
January 1998
Columbia University Mailman School of Public Health, Masters in Science, Epidemiology
January 2005 - January 2005
Harvard Medical School, Doctor of Medicine - MD
January 1994 - January 1999
Frequently Asked Questions about Ouzama Henry
What is Ouzama Henry email address?
Ouzama Henry's primary email address is ******@dynavax.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ouzama Henry work for?
Ouzama Henry is a Associate Director at Dynavax Technologies.
Where Ouzama Henry graduated from?
Ouzama Henry holds a degree in null from Harvard Medical School.
How can I directly contact Ouzama Henry?
To contact Ouzama Henry directly, you can use the email address ******@dynavax.com. Complete contact information is available upon registration with Muraena.
Who is Ouzama Henry?
Ouzama Henry is a seasoned executive in the field of clinical development with nearly two decades of experience, primarily within the pharmaceutical industry. He currently serves as the Vice President of Clinical Development at Dynavax Technologies, where he leads innovative projects in vaccine development. Previously, he held significant roles at Merck and GSK, including Director and Senior Director positions, showcasing his expertise in biologicals and vaccine research. Ouzama is passionate about human health, which is reflected in his academic background, holding an MD from Harvard Medical School and a Master's in Epidemiology from Columbia University. His leadership in clinical research has contributed to advancements in vaccine technology. Ouzama's career is marked by a commitment to improving public health outcomes through scientific innovation and collaboration. He is known for his strategic vision and ability to navigate complex clinical landscapes.
Ouzama`s contact details
******@dynavax.com
Colleagues
Student Technology Assistant, Training & Communications, Information Technology Services
Medical Information Specialist, Medical Information
Process Operator
Design Engineer - Senior Design Engineer - Research Engineer
EMBO Fellowship (Post-Doc)
Group Leader - Genomics
Process Engineer
Merck Manufacturing Development Program
EA to President; EA to VP Market Data; EA to VP Sales
Chief Executive Officer